Gene · 252995
Papers4,118
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
921 to 940 of 4,118
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial. | BMC Endocr Disord | 2023 | 38001474 | PubTator, text mining | PubMed |
| Sex Differences in Bone, Muscle, and Inflammatory Markers and Their Associations with Muscle Performance Variables. | Sports (Basel) | 2023 | 37999432 | PubTator, text mining | PubMed |
| Irisin suppresses pancreatic β cell pyroptosis in T2DM by inhibiting the NLRP3-GSDMD pathway and activating the Nrf2-TrX/TXNIP signaling axis. | Diabetol Metab Syndr | 2023 | 37993958 | PubTator, text mining | PubMed |
| Acute and chronic functional and traditional resistance training improve muscular fitness in young males via the AMPK/PGC-1α/irisin signaling pathway. | Environ Health Prev Med | 2023 | 37967946 | PubTator, text mining | PubMed |
| Methods and research progress in the construction of animal models of osteosarcopenia: a scoping review. | Front Endocrinol (Lausanne) | 2023 | 37964970 | PubTator, text mining | PubMed |
| Oligodendrocyte progenitor cells in Alzheimer's disease: from physiology to pathology. | Transl Neurodegener | 2023 | 37964328 | PubTator, text mining | PubMed |
| Non-drug interventions of traditional Chinese medicine in preventing type 2 diabetes: a review. | Chin Med | 2023 | 37964315 | PubTator, text mining | PubMed |
| Physical exercise for a healthy pregnancy: the role of placentokines and exerkines. | J Physiol Sci | 2023 | 37964253 | PubTator, text mining | PubMed |
| Exercise as a Promising Agent against Cancer: Evaluating Its Anti-Cancer Molecular Mechanisms. | Cancers (Basel) | 2023 | 37958310 | PubTator, text mining | PubMed |
| Irisin protected hemopoietic stem cells and improved outcome of severe bone marrow failure. | Biomed Pharmacother | 2023 | 37952356 | PubTator, text mining | PubMed |
| Physical exercise-intervention can be valuable therapy for COVID-19 confinement and post-COVID-19 periods. | Phys Act Nutr | 2023 | 37946442 | PubTator, text mining | PubMed |
| Author Correction: Disordered metabolism in mice lacking irisin. | Sci Rep | 2023 | 37945614 | PubTator, text mining | PubMed |
| Criteria in the Diagnosis of Metabolic Syndrome in Children: A Scoping Review. | Diabetes Metab Syndr Obes | 2023 | 37942175 | PubTator, text mining | PubMed |
| Editorial: Cardiovascular adaptation to extreme environment, volume II. | Front Cardiovasc Med | 2023 | 37937286 | PubTator, text mining | PubMed |
| Use of a ferroptosis-related gene signature to construct diagnostic and prognostic models for assessing immune infiltration in metabolic dysfunction-associated fatty liver disease. | Front Cell Dev Biol | 2023 | 37928903 | PubTator, text mining | PubMed |
| Physical exercise as a friend not a foe in acute kidney diseases through immune system modulation. | Front Immunol | 2023 | 37928533 | PubTator, text mining | PubMed |
| Omentin-1 ameliorates the progress of osteoarthritis by promoting IL-4-dependent anti-inflammatory responses and M2 macrophage polarization. | Int J Biol Sci | 2023 | 37928270 | PubTator, text mining | PubMed |
| Effect of High-Intensity Resistance Training Versus Endurance Training on Irisin and Adipomyokine Levels in Healthy Individuals: An 8-Week Interventional Study. | Cureus | 2023 | 37927615 | PubTator, text mining | PubMed |
| Mitochondrial disorders as a mechanism for the development of obese Sarcopenia. | Diabetol Metab Syndr | 2023 | 37926816 | PubTator, text mining | PubMed |
| Extracellular nicotinamide phosphoribosyltransferase: role in disease pathophysiology and as a biomarker. | Front Immunol | 2023 | 37915565 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/252995/papers?page=47